Shares of Senseonics Holdings, a medical technology company focused on the development and manufacturing of continuous glucose monitoring systems, surged 5.78% in pre-market trading on Friday.
HC Wainwright & Co. maintained its "Buy" rating and a $2.00 price target on Senseonics, indicating potential upside for the stock. The analyst action appears to be driving the pre-market rally.